(Q44244121)
Statements
Risk factors for hepatotoxicity associated with rifampin and pyrazinamide for the treatment of latent tuberculosis infection: experience from three public health tuberculosis clinics (English)
A M Lee
J Z Mennone
R C Jones
1 November 2002